HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Rick A. Esposito Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Esposito, R. A. Search for Related Content PubMed PubMed Citation Articles by Esposito, R. A. Related Collections Coronary disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Department of Cardiothoracic Surgery, North Shore University Medical Center, 300 Community Dr, Manhasset, NY 11030

(Email: resposit@nshs.edu).

The first 20% of the full text of this article appears below.

In the current era of widespread clopidogrel treatment for acute coronary syndromes and percutaneous coronary interventions, the most intriguing question raised by the study of Gao and colleagues [1] is the effect of clopidogrel on coronary artery bypass graft (CABG) patency. A key finding of this report is the excellent 1-year patency of saphenous vein grafts using clopidogrel treatment only (93.5%) or combined with aspirin (96.3%). This observation represents a significant improvement in vein graft patency over that which has been traditionally reported. Parenthetically, almost identical results on graft patency have been reported in other contemporary studies . . . [Full Text of this Article]

Related Article

Clopidogrel and Aspirin Versus Clopidogrel Alone on Graft Patency After Coronary Artery Bypass Grafting

Changqing Gao, Chonglei Ren, Dong Li, and Libing Li
Ann. Thorac. Surg. 2009 88: 59-62. [Abstract] [Full Text] [PDF]